BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 710477)

  • 1. Effect of immunotherapy on the kinetics of proliferation of a transplanted rat rhabdomyosarcoma.
    Gia DT; Loisillier F
    Eur J Cancer (1965); 1978 Oct; 14(10):1077-88. PubMed ID: 710477
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological studies in murine osteosarcoma. Immunogenicity, growth kinetics, and immunotherapy.
    Miller CW; DeBlasi RF; Fisher SJ
    J Bone Joint Surg Am; 1976 Apr; 58(3):312-7. PubMed ID: 1063129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.
    Spence RJ; Simon RM; Baker AR
    J Natl Cancer Inst; 1978 Feb; 60(2):451-9. PubMed ID: 621758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.
    Sparks FC; Breeding JH
    Cancer Res; 1974 Dec; 34(12):3262-9. PubMed ID: 4471640
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.
    Morton DL; Eilber FR; Joseph WL; Wood WC; Trahan E; Ketcham AS
    Ann Surg; 1970 Oct; 172(4):740-9. PubMed ID: 5272336
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.
    Baldwin RW; Pimm MV
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):875-81. PubMed ID: 4945964
    [No Abstract]   [Full Text] [Related]  

  • 9. Immuno-therapy of methyl cholanthrene induced and spontaneous tumors in mice by use of tumor vaccine, neuraminidase and BCG.
    Gautam S; Aikat BK
    Indian J Med Res; 1976 Mar; 64(3):472-81. PubMed ID: 965048
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy by using cyclophosphamide and tumor-sensitized lymphocytes: a possible mechanism of action.
    Evans R
    J Immunol; 1983 Jun; 130(6):2511-3. PubMed ID: 6133894
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG treatment of transplanted rat tumours of spontaneous origin.
    Pimm MV; Cook AJ; Hopper DG; Dickinson AM; Baldwin RW
    Int J Cancer; 1978 Oct; 22(4):426-32. PubMed ID: 700898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-killed BCG in the treatment of transplanted rat tumours.
    Baldwin RW; Cook AJ; Hopper DG; Pimm MV
    Int J Cancer; 1974 Jun; 13(6):743-50. PubMed ID: 4369104
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
    Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
    Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
    [No Abstract]   [Full Text] [Related]  

  • 14. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacillus Calmette-Guérin contact immunotherapy of local and metastatic deposits of rat tumors.
    Baldwin RW; Hopper DG; Pimm MV
    Ann N Y Acad Sci; 1976; 277(00):124-34. PubMed ID: 1069545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of whole body irradiation on bcg contact suppression of a rat sarcoma and tumour-specific immunity.
    Pimm MV; Baldwin RW
    Br J Cancer; 1976 Aug; 34(2):199-202. PubMed ID: 986827
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of prophylactic and therapeutic administration of BCG vaccine on growth of experimental sarcoma.
    Símová J; Bubeník J
    Folia Biol (Praha); 1975; 21(5):329-33. PubMed ID: 172377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-specific and specific active immunotherapy in a B16 murine melanoma system.
    Avent J; Vervaert C; Seigler HF
    J Surg Oncol; 1979; 12(1):87-96. PubMed ID: 480953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG immunotherapy of rat sarcomata.
    Baldwin RW; Pimm MV
    Br J Cancer; 1973 Jul; 28(1):79. PubMed ID: 4579636
    [No Abstract]   [Full Text] [Related]  

  • 20. BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.
    Baldwin RW; Pimm MV
    Br J Cancer; 1973 Jan; 27(1):48-54. PubMed ID: 4686177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.